Get started
Author

Terence Duane Rhodes

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
2020 · Nicole M Kuderer, Toni K Choueiri, et al. · The Lancet · 1,726
PDF
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
2021 · Michael A. Thompson, Jeffrey P. Henderson, et al. · JAMA Oncology · 192
PDF
High Rates of Human Immunodeficiency Virus Type 1 Recombination: Near-Random Segregation of Markers One Kilobase Apart in One Round of Viral Replication
2003 · Terence Rhodes, Heather Wargo, et al. · Journal of Virology · 138
Identification of a major restriction in HIV-1 intersubtype recombination
2005 · Mario P. S. Chin, Terence D. Rhodes, et al. · Proceedings of the National Academy of Sciences · 104
Genetic Recombination of Human Immunodeficiency Virus Type 1 in One Round of Viral Replication: Effects of Genetic Distance, Target Cells, Accessory Genes, and Lack of High Negative Interference in Crossover Events
2005 · Terence D. Rhodes, Olga Nikolaitchik, et al. · Journal of Virology · 97
An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer
2020 · Tyler Barker, Gail Fulde, et al. · Scientific Reports · 70
PDF
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
2022 · Julie Fu, Sonya A. Reid, et al. · JAMA Network Open · 66
PDF
Effects of Mutations in the Human Immunodeficiency Virus Type 1 gag Gene on RNA Packaging and Recombination
2006 · Olga Nikolaitchik, Terence D. Rhodes, et al. · Journal of Virology · 56
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
2022 · Ziad Bakouny, Chris Labaki, et al. · JAMA Oncology · 54
PDF
Charged Assembly Helix Motif in Murine Leukemia Virus Capsid: an Important Region for Virus Assembly and Particle Size Determination
2003 · Sara Rasmussen Cheslock, Dexter T. K. Poon, et al. · Journal of Virology · 40
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
2021 · Andrew L. Schmidt, Matthew D. Tucker, et al. · JAMA Network Open · 38
PDF
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
2020 · Maheen Abidi, David M. Aboulafia, et al. · Cancer Cell · 31
PDF
Comparison of the Genetic Recombination Rates of Human Immunodeficiency Virus Type 1 in Macrophages and T Cells
2005 · Jianbo Chen, Terence D. Rhodes, et al. · Journal of Virology · 31
An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts.
2020 · Mark R. Middleton, Francesca Aroldi, et al. · Journal of Clinical Oncology · 21
Updated results from the skin cancer cohorts from an ongoing phase 1/2 multicohort study of RP1, an enhanced potency oncolytic HSV, combined with nivolumab (IGNYTE).
2022 · Mohammed M. Milhem, Ari M. Vanderwalde, et al. · Journal of Clinical Oncology · 20
The single-cell spatial landscape of stage III colorectal cancers
2025 · Andrew Su, HoJoon Lee, et al. · npj Precision Oncology · 13
PDF
422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts
2020 · Mark Middleton, Francesca Aroldi, et al. · Regular and Young Investigator Award Abstracts · 13
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
2023 · Shuchi Gulati, Chih-Yuan Hsu, et al. · JAMA Oncology · 10
PDF
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
2022 · Jessica E. Hawley, Tianyi Sun, et al. · JAMA Network Open · 10
PDF
Discovering pathways in the tumor microenvironment important for recurrence-free survival in patients with colorectal liver metastasis.
2012 · Terence Duane Rhodes, Michael Morse, et al. · Journal of Clinical Oncology · 10
Complementary and alternative medicine exposure in oncology (CAMEO) study: A multi-institutional cross-sectional analysis of patients receiving cancer treatment.
2022 · Ryan J. Hutten, Christopher R. Weil, et al. · Journal of Clinical Oncology · 8
Shifting perceptions of alternative therapies in cancer patients during the COVID-19 pandemic: Results from the Complementary and Alternative Medicine Exposure in Oncology (CAMEO) Study.
2022 · Christopher R. Weil, Ryan J. Hutten, et al. · Journal of Clinical Oncology · 5
Abstract LB180: Clinical biomarker studies with two fusion-enhanced versions of oncolytic HSV (RP1 and RP2) alone and in combination with nivolumab in cancer patients indicate potent immune activation
2021 · Kevin J. Harrington, Francesca Aroldi, et al. · Cancer Research · 4
Cost savings of biosimilars in oncology: A single institution experience.
2020 · Megan Mullalley, Whitney Mortensen, et al. · Journal of Clinical Oncology · 3
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
2023 · Douglas B. Johnson, Michael B. Atkins, et al. · BMC Cancer · 2
PDF
Works count: 49
Citation count: 2,785
H-index: 15
I10-index: 21
Year
Topic
Type